News and information about basic science that may lead researchers to develop a cure for HIV – studies of the latent viral reservoir, shock and kill approaches, gene therapies, immune modulators therapeutic vaccines, broadly neutralizing antibodies and so on.

The search for a cure: latest news

The search for a cure resources

The search for a cure features

The search for a cure news from aidsmap

More news

The search for a cure news selected from other sources

  • ‘It’s sobering’: A once-exciting HIV cure strategy fails its test in people

    When Science published a monkey study nearly 2 years ago that showed an anti-inflammatory antibody effectively cured monkeys intentionally infected with the simian form of the AIDS virus, the dramatic results turned many heads. But some skeptical researchers thought the data looked too good to be true and predicted the intervention wouldn’t work on HIV in humans. They were right.

    30 July 2018 | Science
  • Fauci: HIV remission free of antiretroviral therapy is a feasible goal

    Long-lasting control of HIV infection without antiretroviral therapy (ART) is a feasible goal that deserves vigorous pursuit, Anthony S. Fauci, M.D., will assert during a lecture on Wednesday, July 25 at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.

    25 July 2018 | National Institutes of Health
  • Study indicates potential breakthrough HIV drug

    French biotech Abivax announces results of three month course of rev gene disruptor drug ABX464. Reductions in viral DNA seen in 50%. See for earlier study.

    05 July 2018 | Pharmaphorum
  • What’s the fuss about a functional cure?

    A recent study from researchers in Hong Kong has got the world’s media talking about a functional cure for HIV. A quick search for the terms ‘HIV, functional cure, Hong Kong’ yields a long list of articles and videos from around the world. Twitter has also been going crazy. Read on to find out what the researchers did, what they found, and more importantly, what this means for people living with HIV.

    22 June 2018 | HIV Cure
  • Strategies for a cure

    Three researchers talk with PA editor Jeff Berry about ongoing HIV cure research within the ACTG, treatment interruptions, and when we might see a cure.

    12 June 2018 | Positively Aware
  • People with Innate Resistance to HIV Could Provide a Functional HIV Cure

    In the process of studying HIV-infected patients who naturally don’t need therapy to control the virus, scientists have found what could become a functional cure for HIV infections.

    11 June 2018 | (blog)
  • CRISPR Eradicates Latent HIV-1, Offering Hope of "Functional Cures"

    Scientists in Japan have used CRISPR-Cas9 technology to stop human immunodeficiency virus type 1 (HIV-1) replication in latently infected T cells that can’t be controlled using existing drug treatments. The gene-editing approach effectively disrupts two regulatory HIV-1 genes, tat and rev, which are essential for viral replication.

    22 May 2018 | Genetic Engineering & Biotechnology News
  • Discovery of how HIV hedges its bets opens the door to new therapies

    HIV covers its bases in a volatile environment by generating both active and dormant infections. But if the virus is randomly switching between these two fates, how does it ever commit to remaining in one state? Weinberger's laboratory has now answered this longstanding question. Researchers may now be able to continually force HIV back into latency by exploiting the virus's splicing circuit and achieve the "lock and block" therapy.

    11 May 2018 | Eurekalert Medicine & Health
  • Gene editing holds promise for shrinking HIV ‘reservoir’

    Study mimicking Timothy Ray Brown’s HIV-resistant mutation led to fewer latently infected cells — a key step toward driving the virus into remission without the need for antivirals

    27 April 2018 | Fred Hutch
  • Top HIV cure research team refutes major recent results on how to identify HIV persistence

    An international team focused on HIV cure research spearheaded by The Wistar Institute in collaboration with the University of Pennsylvania and Vall d'Hebron Research Institute (VHIR) in Barcelona, Spain, established that the CD32 molecule is not a preferential biomarker to identify HIV silent reservoirs within the immune system of patients undergoing antiretroviral therapy (ART), as proposed by a recent landmark study.

    19 April 2018 | Medical Xpress
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.